Intra-Cellular Therapies to Host First Quarter 2022 Financial Results Conference Call and Webcast
May 03 2022 - 8:00AM
Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a
biopharmaceutical company focused on the development and
commercialization of therapeutics for central nervous system (CNS)
disorders, today announced that it will host a conference call and
live webcast discussion at 8:30 a.m. Eastern Time on Tuesday, May
10, 2022, to provide a corporate update and discuss details of the
Company's financial results for the quarter ended March 31, 2022.
To access the live conference call via phone, dial 1-(844)
835-6563. The international dial-in number is 1-(970) 315-3916. The
conference ID number for the live call is 9526447.
The live and archived webcast can be accessed under "Events
& Presentations" in the Investor Relations section of the
Company's website at www.intracellulartherapies.com. Please log in
approximately 5-10 minutes prior to the event to register and to
download and install any necessary software.
About Intra-Cellular TherapiesIntra-Cellular
Therapies is a biopharmaceutical company founded on Nobel
prize-winning research that allows us to understand how therapies
affect the inner-workings of cells in the body. The company
leverages this intracellular approach to develop innovative
treatments for people living with complex psychiatric and
neurologic diseases.
Contact:Intra-Cellular Therapies, Inc.Juan
Sanchez, M.D. Vice President, Corporate Communications and Investor
Relations646-440-9333
Burns McClellan, Inc.Lisa
Burnscradinovic@burnsmc.com212-213-0006
Intra Cellular Therapies (NASDAQ:ITCI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Intra Cellular Therapies (NASDAQ:ITCI)
Historical Stock Chart
From Apr 2023 to Apr 2024